Action GUBRA GUBRA A/S
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Gubra A/S

Actions

GUBRA

DK0062266474

Marché Fermé - Nasdaq Copenhagen
Autres places de cotation
 17:20:00 28/06/2024 		Varia. 5j. Varia. 1 janv.
489 DKK +6,30% Graphique intraday de Gubra A/S +0,82% +291,20%
25/06 Badaboum Our Logo
25/06 AVIS D'ANALYSTES DU JOUR : Airbus, Kering, Danone, AB Inbev, ArgenX, Nestlé, Nexans, Trigano... Our Logo

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
OPINIONI DEGLI ANALISTI DEL GIORNO : Saipem, Moncler, Kering, Santander, Intensa Sanpaolo, Eni, AB Inbev, ArgenX, Nestlé, Fincantieri, Ferrari...
OPINIONES DE LOS ANALISTAS DEL DÍA : Acciona, Airbus, Kering, Banco Santander, Moncler, Eni, AB Inbev, ArgenX, Nestlé, Caixabank, Grifols...
Borsa di Italia: Bang!
Bolsa de Madrid: ¡Bang!
Gubra A/S Announces Management Changes
Gubra Unveils UCN2 as Novel Anti-Obesity Drug Candidate for Healthy Weight Loss
Certain Shares of Gubra A/S are subject to a Lock-Up Agreement Ending on 29-MAR-2024.
Gubra Concludes the Research Agreement with Silence Therapeutics plc
Gubra and Boehringer Ingelheim Sign 4Th Partnership, Expanding Their Successful Obesity Treatment Discovery Collaboration
Gubra A/S Announces First Subject Dosed in Phase 1 Clinical Trial of Amylin Agonist for the Treatment of Obesity
Gubra A/S Announces Board Appointments
Gubra Raises Earnings Guidance for Full-Year 2023
Denmark's Gubra Opens First US Office Under Expansion Strategy
Gubra A/S Opens Its First US Office in Boston
Gubra Seeks UK Regulatory Approval to Begin Human Trial for Anti-Obesity Drug
Gubra A/S Submits Clinical Trial Application for First-In-Human Amylin Trial
Tranche Update on Gubra A/S's Equity Buyback Plan announced on June 30, 2023.
Gubra Announces Termination of Collaboration with Bayer AG
Gubra A/S Raises Financial Guidance for Full-Year 2023
Gubra A/S commences an Equity Buyback Plan for 1,180,424 shares, under the authorization approved on March 16, 2023.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action GUBRA
  4. Actualités Gubra A/S
  5. Autres langues